Partner Content Partner Content GSK explores Oral Lipid Based Formulations & Taste Maski... GSK explores Oral Lipid Based Formulations
Partner Content Partner Content Agenda released for SMi Group’s Controlled Release Delivery ... Agenda released for Controlled Release Delivery 2018
News Hengrui to file obesity shot in China after phase 3 win An obesity therapy developed Hengrui Pharma and Kailera is being prepared for its first regulatory submission, in China.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
